India’s Natco Pharma sued in US
Chennai, Sep 8 (IANS) The Hyderabad based pharmaceutical major Natco Pharma (NS:NATP) Ltd on Friday said the company and others have been named as defendants in a case filed in the US. In a...
-
-
Pharma stock falls more than 3% after company gets involved in a US lawsuit; Check the details
This small cap pharma stock slumped 4% in the first half on Friday after the company announced its involvement in an antitrust lawsuit in the US by Louisiana Health Service & Indemnity...
-
Adani Ports, IRCTC, Apollo Hospitals to Release Q4 in Final Earnings Week
By Malvika Gurung Investing.com -- The week starting on May 29, 2023, will be lined with more than 1,700 companies releasing their earnings results for the quarter ended March 31, 2023. This...
-
Natco Pharma Leads Nifty Pharma Pack Ahead of Share Buyback Proposal
By Malvika Gurung Investing.com -- Shares of the pharmaceutical company Natco Pharma (NS:NATP) gained 2.93% to Rs 569.4 apiece in early trade on Friday after the company announced to...
-
Key Stocks in Focus Today: HDFC, Tata Motors, Bajaj Consumer, Natco Pharma & More
By Malvika Gurung Investing.com -- Tata Motors (NS:TAMO): The domestic automaker is considering hiking its passenger vehicle prices from Jan 2023 so that its model range becomes compliant...
-
2 Beaten down stocks in which analysts see up to 50% upside; is it a good time to buy?
Amid a choppy session on Friday, benchmark indices recovered most of their losses, tracking mixed moves across global markets. Worries remained about the impact of aggressive hikes in...
-
Mkt-Mover Alert: Key Q2 Results Ahead- Tata Motors, LIC, Coal India, BPCL & More
By Malvika Gurung Investing.com -- The domestic market made a higher closing on Friday, snapping two sessions of losses, with the equity benchmark indices ending the week with up to 2%...
-
Stocks in Focus on Sept 20: Adani Enterprises, CEAT, Crompton Greaves & More
By Malvika Gurung Investing.com -- Adani Enterprises (NS:ADEL): The flagship company of the ports-to-power conglomerate has raised Rs 100 crore by allotting 1,000 NCDs on a private...
-
In Focus: BPCL, Sun Pharma, Power Grid & Other Key Cos to Trade Ex-Dividend
By Malvika Gurung Investing.com -- Shares of many companies, including major public sector heavyweights will trade ex-dividend on Friday, Aug 19. A non-exhaustive list of companies going...
-
Natco Pharma Surges on Launching Revlimid Version in US; Zooms 9% in Early Trade
By Malvika Gurung Investing.com -- Shares of the pharmaceutical company Natco Pharma (NS:NATP) traded 3.8% higher at 10 am, after zooming 9% in early trade on Tuesday, in response to the...
-
Stocks in Focus on March 8: Dish TV, Natco Pharma, Metro Brands & More
By Malvika Gurung Investing.com -- Larsen & Toubro (NS:LART): The engineering and construction major launched its own B2B e-commerce platform, called L&T SuFin. Axis Bank (NS:AXBK): The...
-
Stocks in Focus on Feb 14: ONGC, TVS Motor, Coal India & More
By Malvika Gurung Investing.com -- ONGC (NS:ONGC): The state-run gas major reported a whopping 596.7% YoY jump in net profit at Rs 8,764 crore in the December ending period after higher oil...
-
Nifty50 Pares Early Losses, Up 0.5%; Nifty Pharma Top Sectoral Gainer
By Malvika Gurung Investing.com -- After opening almost 1% lower on Monday, following mixed cues from Asian markets, Indian equity benchmark indices Nifty50 and BSE Sensex have pared losses...
-
2 Pharma Stocks that Zoomed Due to COVID Drugs
By Aditya Raghunath Investing.com -- The second wave of the coronavirus keeps mutating and its side effects are as bad as the disease itself. While the number of infections has been steadily...
-
UPDATE 1-India approves Roche/Regeneron antibody cocktail to treat COVID-19
(Adds details on the drug, background)BENGALURU, May 5 (Reuters) - India has given emergency use authorization for a COVID-19 antibody drug cocktail developed by Roche ROG.S and Regeneron...
-
BRIEF-Natco Pharma Gets Emergency Use Nod For Baricitinib Tablets For COVID-19 Treatment
May 3 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO RECEIVES EMERGENCY USE APPROVAL FOR BARICITINIB TABLETS FOR COVID-19 TREATMENT* NATCO WILL BE REQUESTING A COMPULSORY LICENSE BASED ON...
-
BRIEF-India's Natco Pharma Ltd Says To Acquire 0.96% Stake In Natco Pharma (Canada) Inc
March 26 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA LTD - TO ACQUIRE 0.96% STAKE IN NATCO PHARMA (CANADA) INC...
-
BRIEF-Natco Pharma Forays Into Pheromone Based Technology For Integrated Pest Management
March 15 (Reuters) - Natco Pharma Ltd NATP.NS :* FORAYS INTO PHEROMONE BASED TECHNOLOGY FOR INTEGRATED PEST MANAGEMENT* DURING KHARIF 2021, NATCO PLANS TO LAUNCH ITS FIRST GREEN LABEL...
-
BRIEF-Natco Pharma Ltd Says Launches Brivaracetam Tablets, In India For Treatment Of Epilepsy
Feb 26 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA LTD SAYS LAUNCHES BRIVARACETAM TABLETS, IN INDIA, FOR TREATMENT OF EPILEPSY...
-
BRIEF-Natco Pharma Dec-Qtr Consol Profit Falls
Feb 11 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA LTD DEC-QUARTER CONSOL PROFIT 627 MILLION RUPEES VERSUS 1.05 BILLION RUPEES YEAR AGO* NATCO PHARMA LTD DEC-QUARTER CONSOL...
-
BRIEF-Natco Pharma Launches Anti Blood Clot Tablet Rivaroxaban In India
Dec 17 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA LTD - LAUNCHES ANTI BLOOD CLOT TABLET RIVAROXABAN IN INDIA...
-
BRIEF-Natco Pharma Sept-Qtr Consol Net Profit Rises
Nov 12 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA LTD SEPT-QUARTER CONSOL NET PROFIT 2.02 BILLION RUPEES VERSUS 1.19 BILLION RUPEES YEAR AGO* NATCO PHARMA LTD SEPT-QUARTER CONSOL...
-
BRIEF-Natco Pharma Says Buys Shares In Unit Amounting To $727,100
Sept 10 (Reuters) - Natco Pharma Ltd NATP.NS :* NATCO PHARMA -PURCHASE OF SHARES IN UNIT AMOUNTING TO $727,100...
-
BRIEF-India's Natco Pharma June-Qtr Consol Profit Falls
Aug 12 (Reuters) - Natco Pharma Ltd NATP.NS :* JUNE-QUARTER CONSOL PROFIT 1.22 BILLION RUPEES VERSUS PROFIT 1.43 BILLION RUPEES YEAR AGO* JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 5.63...
-
BRIEF-Natco Pharma Donating Chloroquine Phosphate Tablets For Columbia University's Trial
May 22 (Reuters) - Natco Pharma Ltd NATP.NS :* DONATING CHLOROQUINE PHOSPHATE TABLETS, THROUGH U.S. MARKETING PARTNER, TO COLUMBIA UNIVERSITY* DONATION FOR COLUMBIA UNIVERSITY'S...
-
BRIEF-Natco Pharma Ltd's Vizag Formulation Facility Gets U.S. FDA Approval
April 28 (Reuters) - Natco Pharma Ltd NATP.NS :* VIZAG FORMULATION FACILITY RECEIVES USFDA APPROVAL...
-
BRIEF-FDA Completes Inspection Of India's Natco Pharma's Kothur Formulation Facility
March 6 (Reuters) - Natco Pharma Ltd NATP.NS :* U.S. FDA COMPLETES INSPECTION OF NATCO'S KOTHUR FORMULATION FACILITY* KOTHUR FORMULATION FACILITY GOT SINGLE OBSERVATION RELATED TO...
-
BRIEF-India's Natco Pharma Dec Quarter Consol Profit Falls
Feb 12 (Reuters) - Natco Pharma Ltd NATP.NS :* DEC QUARTER CONSOL NET PROFIT 1.05 BILLION RUPEES VERSUS 1.6 BILLION RUPEES YEAR AGO* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 4.82 BILLION...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
